Balyasny Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-13,286
| Closed | -$127K | – | 2102 |
|
|
2024
Q4 | $127K | Buy |
+13,286
| New | +$127K | ﹤0.01% | 1794 |
|
|
2023
Q1 | – | Sell |
-1,115
| Closed | -$13.2K | – | 2306 |
|
|
2022
Q4 | $13.2K | Sell |
1,115
-545,718
| -100% | -$6.44M | ﹤0.01% | 2091 |
|
|
2022
Q3 | $11.5M | Buy |
+546,833
| New | +$11.5M | 0.04% | 509 |
|
|
2021
Q1 | – | Sell |
-30,697
| Closed | -$2.75M | – | 1645 |
|
|
2020
Q4 | $2.75M | Buy |
+30,697
| New | +$2.75M | 0.02% | 680 |
|
|
2020
Q2 | – | Sell |
-56,045
| Closed | -$3.24M | – | 1045 |
|
|
2020
Q1 | $3.24M | Buy |
+56,045
| New | +$3.24M | 0.04% | 435 |
|
|
2018
Q2 | – | Sell |
-6,961
| Closed | -$366K | – | 1659 |
|
|
2018
Q1 | $366K | Buy |
+6,961
| New | +$366K | ﹤0.01% | 1360 |
|
|
2016
Q2 | – | Sell |
-6,031
| Closed | -$219K | – | 1036 |
|
|
2016
Q1 | $219K | Buy |
6,031
+600
| +11% | +$21.8K | ﹤0.01% | 897 |
|
|
2015
Q4 | $217K | Buy |
+5,431
| New | +$217K | ﹤0.01% | 941 |
|